10年后,英国的药品早期获取计划:使用公开可用的数据进行评估
Pandora Pound1, Rebecca Ram1, Kathy Archibald1
1Safer Medicines Trust, Kingsbridge, TQ7 9AX, UK.
JRSM open
|February 26, 2025
概括
英国的早期获取药物计划 (EAMS) 主要是批准的癌症药物,通常具有有限的试验数据和替代结果. 许多EAMS药物出现了较高的不良反应报告,需要进一步审查和以患者为中心的结果关注.
科学领域:
- 药物监督 药物监督 药物监督
- 监管科学 监管科学
- 在瘤学瘤学.
背景情况:
- 英国的药物早期准入计划 (EAMS) 提供了对创新药物的批准前准入.
- 评估EAMS批准药物的证据基础和安全概况对于患者安全和监管监督至关重要.
研究的目的:
- 评估通过EAMS批准的药物和适应症.
- 为了确定监管机构考虑包含在EAMS中的证据.
- 为了确定与EAMS药物相关的潜在患者风险.
主要方法:
- 从MHRA公开评估报告,电子药物汇编,药物分析档案和Eudravigilance中分析公开可用的数据.
- 来自MHRA网站的51个科学意见的审查 (2024年6月).
主要成果:
- 分析了48份EAMS提交 (32种药物,48种适应症);60%的适应症是癌症.
- 只有7%的提交基于双盲,安慰剂对照试验;大多数使用代孕或生存结果.
- 47%的药物出现了较高的不良反应报告,17%没有正在进行的研究.
结论:
- 建议包括审查具有高不良事件率的EAMS药物.
- 未来的EAMS研究应该优先考虑以患者为中心的结果和基于人类生物学的临床前方法.
- 批准后的试验和患者经验应该是未来EAMS审查的核心.
更多相关视频
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
509
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Control Governance: Regulatory Bodies and Their Impact
135
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
135
